Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

More than 800 million adults worldwide are living with diabetes, according to a new study in the journal The Lancet. The global rate of diabetes was about 14% in 2022, the study found. Nearly 60% of a ...

Diabetes is one of the biggest global health concerns at the moment. While many people may not realize, that diabetes has ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Dr. Diana Bitner talks about just how easy— and hard— it can be to plan your meals with your prediabetic and diabetic risk ...

The pandemic had large-scale effects on our collective wellbeing that, almost five years later, it can be easy to forget once ...

Diabetes Awareness Month is this November, and surprisingly, one in three Wyomingites have pre-diabetes and do not know it.

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

The study showed those who develop type 2 diabetes before the age of 60 have three times the risk of getting dementia later in life.